CLDN18.2/PD-L1 dual-target CAR-T

· Sichuan University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CLDN18.2/PD-L1 dual-target CAR-T, covering 2024-11-19 to 2024-11-19. Get the full timeline:

Most recent: Clinical Trial Update: Dual-targeting CLDN18.2 and PD-L1 CAR-T for Patients with CLDN18.2-positive Advanced Solid Tumors [Phase 1]